Innovator IBD ETF Leaders ETF
LDRS
LDRS was delisted on the 13th of August, 2021.
13 hedge funds and large institutions have $4.97M invested in Innovator IBD ETF Leaders ETF in 2018 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 5 closing their positions.
28% less funds holding
Funds holding: 18 → 13 (-5)
31% less capital invested
Capital invested by funds: $7.18M → $4.97M (-$2.21M)
50% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 8
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$280K |
| 2 |
Jane Street
New York
|
+$99.6K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$8.57K |
| 4 |
Koshinski Asset Management
Decatur,
Illinois
|
+$7.54K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
-$548K |
| 2 |
SWP
Stratos Wealth Partners
Beachwood,
Ohio
|
-$293K |
| 3 |
CAN
Claraphi Advisory Network
Aliso Viejo,
United States
|
-$276K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$167K |
| 5 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
-$135K |
LDRS Hedge Fund Activity: Q4 2018 in Review
13 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Innovator IBD ETF Leaders ETF (LDRS) for Q4 2018, worth a combined $4.97M — down 31% from $7.18M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of LDRS and 0 opened new positions — a net loss of 5 holders — while 8 trimmed existing stakes and 4 added.
The largest buyer was Citadel Advisors, adding an estimated $280K. The largest seller was Raymond James Financial Services Advisors, exiting entirely with an estimated $548K sold.
- 13 institutional investors held Innovator IBD ETF Leaders ETF (LDRS) as of Q4 2018, down from 18 in Q3 2018.
- Funds reported $4.97M of Innovator IBD ETF Leaders ETF stock for Q4 2018, down 31% quarter-over-quarter.
- 0 funds opened new Innovator IBD ETF Leaders ETF positions in Q4 2018 and 5 closed out, a net change of -5 holders.
- The largest Innovator IBD ETF Leaders ETF buyer in Q4 2018 was Citadel Advisors, an estimated $280K added.
- The largest Innovator IBD ETF Leaders ETF seller in Q4 2018 was Raymond James Financial Services Advisors, an estimated $548K sold.
Based on aggregated 13F filings for Q4 2018.